[
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price target. The positive stance comes as the company plans to launch Bolt’s laser-based intravascular lithotripsy (IVL) system for peripheral use in late […]",
    "url": "https://finnhub.io/api/news?id=417da7c9981c9f31578e6ad56d6ced2400bd1f9c7bc4068c98a2775216471e37",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758217201,
      "headline": "Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity",
      "id": 136801254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price target. The positive stance comes as the company plans to launch Bolt’s laser-based intravascular lithotripsy (IVL) system for peripheral use in late […]",
      "url": "https://finnhub.io/api/news?id=417da7c9981c9f31578e6ad56d6ced2400bd1f9c7bc4068c98a2775216471e37"
    }
  },
  {
    "ts": null,
    "headline": "Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=37e3305fbdefe9971e5b2d99c358e5356c6f53440c3e7f3d9df1cddd04825602",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758206702,
      "headline": "Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term",
      "id": 136799629,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=37e3305fbdefe9971e5b2d99c358e5356c6f53440c3e7f3d9df1cddd04825602"
    }
  },
  {
    "ts": null,
    "headline": "Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio",
    "summary": "AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.",
    "url": "https://finnhub.io/api/news?id=144f1486454d70084eda0afce16a6863a5710706d9d30b906ac725ae9a0724e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758202920,
      "headline": "Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio",
      "id": 136799630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.",
      "url": "https://finnhub.io/api/news?id=144f1486454d70084eda0afce16a6863a5710706d9d30b906ac725ae9a0724e2"
    }
  },
  {
    "ts": null,
    "headline": "Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy",
    "summary": "ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.",
    "url": "https://finnhub.io/api/news?id=0b2a05873f037d6894bf900b24bcb8e683c5862692b2e63c19d48ff32d0a4b62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758202860,
      "headline": "Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy",
      "id": 136799631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.",
      "url": "https://finnhub.io/api/news?id=0b2a05873f037d6894bf900b24bcb8e683c5862692b2e63c19d48ff32d0a4b62"
    }
  }
]